Marine-Based Support for Stress Resilience, Mood, and Clarity*
What It Does
Stabilium® 200 is a French marine-based dietary supplement designed to support emotional resilience, stress adaptation, and cognitive performance.* It contains Garum Armoricum®, a fish protein hydrolysate with a long tradition of use and growing modern research support for its benefits in managing psychological and physiological stress.*
How It Works
• Garum Armoricum®, derived from Blue Ling fish (Molva dypterygia), provides low molecular weight peptides and free amino acids that support neurological, immune, and metabolic functions.*[1]
• Shown in animal studies to reduce corticosterone secretion and support hippocampal neuron health under stress.*[4-5]
• In preclinical models, increased exploratory behavior and reducing immobility in stress paradigms.*[2-3]
• Supports focus and motivation, with human trials showing improved mood, learning, and mental clarity in older adults and students under exam stress.*[6-8]
• Also includes vitamins B6, E, and A, along with omega-3 fatty acids, glycine, glutamic acid, and tryptophan to support neurotransmitter synthesis and cellular health.*
• Fermentation-inspired enzymatic processing, modeled after ancient Celtic techniques, ensures purity and preserves peptide bioactivity.*
• With no observed rebound or dependence phenomena in human studies.*
Who It’s For
Ideal for adults experiencing mental stress or those seeking gentle, natural support for emotional and cognitive clarity and resilience.*
Special Features
Imported from France and produced using a unique enzymatic process to yield a standardized composition containing neuroactive peptides and amino acids. Stabilium® 200 combines historical use with emerging scientific validation for stress modulation.*
References
1. Zamora-Sillero J et al. Mar Biotechnol (NY). 2018;20(2):118–30.
2. Messaoudi M et al. Curr Top Nutraceutical Res. 2008;6:115–23
3. Messaoudi M et al. Curr Top Nutraceutical Res. 2008 Feb;6(1)
4. Dinel A-L et al. J Funct Foods. 2021;76:104292. doi:10.1016/j.jff.2020.104292
5. Le Faouder J et al. Foods. 2022;11(11):1591. doi:10.3390/foods11111591
6. Le Poncin M. J Eur Coll Neuropsychopharmacol. 1996;6(3):110
7. Messaoudi M et al. Fund Clin Pharmacol. 2009;23(1):74
8. Dorman T et al. J Adv Med. 1995;8(3):193–00.
9. Cheung RC et al. Mar Drugs. 2015;13(7):4006–43. doi:10.3390/md13074006
